BD Rapid Detection of SARS‑CoV‑2 ART Self Antigen Test Kit, 5pcs / Box, (Expiry: Feb 2022)

The BD Kit for Rapid Detection of SARS‑CoV‑2 is a chromatographic immunoassay intended for the direct and qualitative detection of SARS‑CoV‑2 nucleocapsid antigens in nasal swabs from individuals who are without symptoms, or with symptoms, who are suspected of SARS‑CoV‑2 infection by their healthcare provider.

Visually read results are for the identification of SARS‑CoV‑2 nucleocapsid antigen. This antigen is generally detectable in upper respiratory samples during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status.

The BD Kit for Rapid Detection of SARS‑CoV‑2 is intended for use in point of care settings by healthcare professionals or trained users specifically instructed in the use of the BD Kit for Rapid Detection of SARS‑CoV‑2 and proper infection control procedures.

HSA & MOH APPROVED

Get ready for SARS-CoV-2 testing

When your patients are in need of reliable and rapid SARS-CoV-2 testing, turn to the BD Kit for Rapid Detection of SARS-CoV-2. Offering an easy-to-use point of care test, with results in approximately 15 minutes.

One result

• Assay results designed to be read visually
• Indicated for use in both asymptomatic and symptomatic individuals, who are suspected of SARS-CoV-2 infection by their healthcare provider
• Results in approximately 15 minutes
• Easily performed & interpreted by a healthcare professional or self-testing.
• Detection of SARS-CoV-2 antigen (nucleocapsid protein), in nasal swabs
• Reliable results, 91% PPA* compared to reference PCR method
• Provides intuitive sample processing with prefilled, single-use reaction tubes